Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

HC Wainwright Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)

Summary by reporter.am
Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a note issued to investors on Friday, MarketBeat.com reports. They currently have a $15.00 price target on the stock, up from their prior price target of $12.00. HC Wainwright’s target price indicates a potential upside of […]
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock MarketsStock Markets
North CarolinaNorth Carolina
US EconomyUS Economy
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal